Amgen Inc
AMGNAmgen Inc. is a global biopharmaceutical company focused on developing and manufacturing innovative medicines in areas such as oncology, nephrology, and inflammation. Founded in 1980, Amgen is known for its work in biologic therapies and has a strong portfolio of blockbuster drugs aimed at improving patient lives.
Dividend History
Investors can expect a dividend payout of $2.52 per share, scheduled to be distributed in 81 days on March 6, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| March 6, 2026 | $2.52 | 2026-02-13 | 2026-02-13 |
| December 12, 2025 | $2.38 | 2025-11-21 | 2025-11-21 |
| September 12, 2025 | $2.38 | 2025-08-22 | 2025-08-22 |
| June 6, 2025 | $2.38 | 2025-05-16 | 2025-05-16 |
| March 7, 2025 | $2.38 | 2025-02-14 | 2025-02-14 |
Dividends Summary
- Amgen Inc has issued 59 dividend payments over the past 15 years
- The most recent dividend was paid 3 days ago, on December 12, 2025
- The highest dividend payed out to investors during this period was $2.52 per share
- The average dividend paid during this period was $1.35 per share.
Company News
The Schwab U.S. Dividend Equity ETF offers a reliable long-term passive income strategy, featuring consistent dividend growth, quality companies, and a current yield of 3.8%, making it attractive for investors seeking steady income over decades.
The FDA approved Amgen's UPLIZNA® (inebilizumab-cdon) as the first CD19-Targeted B-Cell therapy for generalized myasthenia gravis, offering patients a new treatment option with potential long-term disease control using just two doses annually.
The FDA approved Amgen's drug Uplinza for generalized myasthenia gravis (gMG), offering a new targeted treatment option for adult patients with specific antibody conditions, requiring only two doses annually after initial loading doses.
Amgen reported strong quarterly earnings, beating revenue and EPS estimates, with robust performance across drug portfolios and positive momentum signaling potential new stock highs.
The article discusses the Invesco Large Cap Value ETF (PWV), which provides broad exposure to the large-cap value segment of the market. It highlights the fund's investment strategy, performance, and risk profile, as well as compares it to similar ETFs like Schwab U.S. Dividend Equity ETF (SCHD) and Vanguard Value ETF (VTV).
